COVID-19 Raises Heart Attack, Stroke Risk for Up to Three Years
Individuals infected with COVID-19 early in the pandemic faced an increased risk of heart attack, stroke, and death for up to three years following initial infection.
Individuals infected with COVID-19 early in the pandemic faced an increased risk of heart attack, stroke, and death for up to three years following initial infection.
Scientists have discovered a mutation in the SARS-CoV-2 spike protein that enhances the virus' ability to infect the brain.
UCSF research reveals that long COVID "is not a mystery," providing evidence of virus persistence and sustained immune activation.
At-home antibody tests can help determine if individuals have adequate immunity against COVID-19 and potentially guide decisions on the need for booster shots.
Read MoreResearchers utilized AI to analyze CT scans, discovering lung deformities to the surfaces of the lungs in severe COVID-19 patients.
Read MoreCOVID-19 patients, even those with mild cases initially, face an elevated risk of death and a range of adverse health conditions up to three years after their initial infection.
Read MoreThe Cleveland Clinic ReCOVer Clinic is enrolling Long COVID patients in the NIH RECOVER-VITAL clinical study.
Read MoreThe trials will investigate potential treatments for long COVID-related sleep disturbances, exercise intolerance, and post-exertional malaise.
Read MoreInfants who experience severe respiratory syncytial virus infections face increased risk of structural lung changes that could impair their respiratory health into adulthood, research suggests.
Read MoreNearly one-quarter of adults age 50 or older hospitalized with RSV experienced an acute cardiac event, including those with no previous cardiovascular disease.
Read MoreResearchers have identified a new complex-carbohydrate biomolecule, or glycan, that plays a key role in the nasal colonization of the Bordetella bacteria responsible for whooping cough.
Read MoreA study examined the efficacy of a six-week intervention, consisting of weekly one-hour sessions combining heart rate variability and temperature biofeedback.
Read MoreA study of more than 600,000 individuals shows that 4 in 5 with TB have no persistent cough, previously believed to be the most common symptom of the infectious disease.
Read MoreTwo phase 2 trials will evaluate the safety and effectiveness of the therapies for symptoms such as fast heart rate, dizziness, and fatigue.
Read MoreWith measles cases on the rise across the US, experts at the National Foundation for Infectious Diseases are urging the public to follow longstanding public health recommendations by making sure they are up to date on measles-mumps-rubella vaccination.
Read More